CD4+ T helper cells engineered to produce latent TGF-β1 reverse allergen-induced airway hyperreactivity and inflammation

Journal of Clinical Investigation

Volumn 105, Issue 1, 2000, Pages 61-70

  Hansen, Gesine ^a   McIntire, Jennifer J ^a   Yeung, V Peter ^a   Berry, Gerald ^b   Thorbecke, G Jeanette ^c   Chen, Lizhen ^c   DeKruyff, Rosemarie H ^a   Umetsu, Dale T ^a  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; GENE THERAPY; HELPER CELL; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INFLAMMATION; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033987397     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7589     Document Type: Article

References (57)

1. 1998, Forecasted state-specific estimates of self-reported asthma prevalence - United States, 1998. MMWR Morb. Mortal. Wkly. Rep. 47:1022-1025
2. Shirakawa, T., Enomoto, T., Shimazu, S., and Hopkin, J.M. 1997. The inverse association between tuberculin responses and atopic disorder. Science. 275:77-79.
3. + cells in human allergic diseases. J. Allergy. Clin. Immunol. 100:1-6.
4. Wills-Karp, M., et al. 1998. Interleukin-13: central mediator of allergic asthma. Science. 282:2258-2261.
5. Romagnani, S. 1994. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol 12:227-257.
6. Hansen, G., Berry, G., DeKruyff, R.H., and Umetsu, D.T. 1999. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J. Clin. Invest. 103:175-183.
7. Shull, M., et al. 1992. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 359:693-699
8. Kulkarni, A.B., et al. 1993. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl Acad. Sci USA. 90:770-774.
9. Kulkarni, A.B., and Karlsson, S. 1993. Transforming growth factor-beta 1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease. Am. J. Pathol. 143:3-9.
10. Vodovotz, Y., et al. 1996. Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor beta 1 null mouse. J Exp. Med. 183:2337-2342.
11. Kehrl, J.H., et al. 1986. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. J. Immunol. 137:3855-3860.
12. Wahl, S.M., et al. 1988. Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J Immunol. 140:3026-3032.
13. Espevik, T., et al. 1987. Inhibition of cytokine production by cyclosporin A and transforming growth factor beta. J. Exp. Med. 166:571-576.
14. Barral-Netto, M., et al. 1992. Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. Science. 257:545-548.
15. Brandes, M.E., Allen, J.B., Ogawa, Y., and Wahl, S.M. 1991. Transforming growth factor beta I suppresses acute and chronic arthritis in experimental animals. J. Clin. Invest. 87:1108-1113.
16. Kuruvilla, A.P., et al. 1991. Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. Proc. Natl. Acad. Sci. USA. 88:2918-2921.
17. Chen, Y., Kuchroo, V.K., Inobe, J., Hafler, D.A., and Weiner, H.L. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 265:1237-1240.
18. Thorbecke, G.J., et al. 1992. Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice. Proc. Natl. Acad. Sci. USA. 89:7375-7379.
19. Santambrogio, L., et al. 1993. Studies on the mechanisms by which transforming growth factor-beta (TGF-beta) protects against allergic encephalomyelitis. Antagonism between TGF-beta and tumor necrosis factor. J. Immunol. 151:1116-1127.
20. Neurath, M.F., et al. 1996. Experimental granulomatous colitis in mice is abrogated by induction of TGF-mediated oral tolerance. J. Exp. Med. 183:2605-2616.
21. Weiner, H.L. 1997. Oral tolerance for the treatment of autoimmune diseases. Annu. Rev. Med. 48:341-351.
22. Weiner, H.L., et al. 1994. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12:809-837.
23. Chen, L.Z., et al. 1998. Gene therapy in allergic encephalomyelitis using MBP-specific T cells engineered to express latent TGF-β1. Proc. Natl. Acad. Sci. USA. 95:12516-12521.
24. Bosma, G.C., Custer, R.P., and Bosma, M.J. 1983. A severe combined immunodeficiency mutation in the mouse. Nature. 301:527-530.
25. 16 thymocytes in vivo. Science. 250:1720-1723.
26. DeKruyff, R.H., Fang, Y., and Umetsu, D.T. 1998. Corticosteroids enhance the capacity of macrophages to induce Th2 cytokine synthesis in CD4+ lymphocytes by inhibiting interleukin-12 production. J. Immunol. 160:2231-2237.
27. Danos, O., and Mulligan, R.C. 1988. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. USA. 85:6460-6464.
28. Tsuyuki, S., Stuyuki, J., Einsle, K., Kopf, M., and Coyle, A.J. 1997. Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal Th2 immune response and altered airway responsiveness. J. Exp. Med. 185:1671-1679.
29. Like, B., and Massague, J. 1986. The antiproliferative effect of type beta transforming growth factor occurs at a level distal from receptors for growth-activating factors. J. Biol. Chem. 261:13426-13429.
30. Kelley, J., Baldor, L., and Absher, M. 1992. Complex cytokine modulation of a continuous line of mink lung epithelial cells (Mv1Lu). Exp. Lung. Res. 18:877-887.
31. Macaulay, A.E., DeKruyff, R.H., and Umetsu, D.T. 1998. Antigen-primed T cells from B cell-deficient JHD mice fail to provide B cell help. J Immunol 160:1694-1700.
32. Murphy, E., et al. 1996. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J. Exp. Med 183:901-913.
33. Chen, W., Jin, W., and Wahl, S.M. 1998. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor β (TGF-β) production by murine CD4+ T cells. J. Exp. Med. 188:1849-1857.
34. DeKruyff, R.H., Ju, S.-T., Hunt, A.J., Mosmann, T.R., and Umetsu, D.T. 1989. Induction of antigen-specific antibody responses in primed and unprimed B cells: functional heterogeneity among Th1 and Th2 T cell clones. J Immunol. 142:2575-2582.
35. Oro, A.S., Guarino, T.J., Driver, R., Steinman, L., and Umetsu, D.T. 1996. Regulation of disease susceptibility: decreased prevalence of IgE-mediated allergic disease in patients with multiple sclerosis. J. Allergy Clin. Immunol. 97:1402-1408.
36. Secrist, H., Chelen, C.J., Wen, Y., Marshall, J.D., and Umetsu, D.T. 1993. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J. Exp. Med. 178:2123-2130.
37. Jutel, M., et al. 1995. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures. J. Immunol. 154:4187-4194.
38. Varney, V.A., et al. 1993. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J. Clin Invest. 92:644-651.
39. Kim, T.S., et al. 1997. An OVA-IL-12 fusion protein is more effective than OVA plus rIL-12 in inducing a Th1-dominated immune response and inhibiting antigen-specific IgE production. J. Immunol. 158:4137-4144.
40. Yeung, V.P., Gieni, R.S., Umetsu, D.T., and DeKruyff, R.H. 1998. Heat killed Listeria monocytogenes as an adjuvant converts established Th2-dominated immune responses into Th1-dominated responses. J. Immunol 161:4146-4152.
41. Hsu, C.H., et al. 1996. Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization. Nat. Med. 2:540-544.
42. Raz, E., et al. 1996. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc. Natl. Acad. Sci. USA. 93:5141-5145.
43. Gavette, S.H., et al. 1995. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182:1527-1536.
44. Randolph, D.A., Carruthers, C.J., Szabo, S.J., Murphy, K.M., and Chaplin, D.D, 1999. Modulation of airway inflammation by passive transfer of allergen-specific Th1 and Th2 cells in a mouse model of asthma. J. Immunol. 162:2375-2383.
45. Groux, H., et al. 1997. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 389:737-742.
46. Haneda, K., et al. 1997. TGF-beta induced by oral tolerance ameliorates experimental tracheal eosinophilia. J. Immunol. 159:4484-4490.
47. Bridoux, F., et al. 1997. Transforming growth factor β (TGF-β)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4+ T cell lines. J. Exp. Med. 185:1769-1775.
48. Johns, L.D., Flanders, K.C., Ranges, G.E., and Sriram, S. 1991. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1. J. Immunol 147:1792-1796.
49. Racke, M.K., et al. 1992. Evidence of endogenous regulatory function of transforming growth factor-beta 1 in experimental allergic encephalomyelitis. Int. Immunol. 4:615-620.
50. Rizzo, L.V., et al. 1994. Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity. J. Clin. Invest. 94:1668-1672.
51. Khalil, N., O'Connor, R.N., Flanders, K.C., and Unruh, H. 1996. TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. Am. J. Respir. Cell. Mol. Biol. 14:131-138.
52. Letterio, J.J., and Roberts, A.B. 1998. Regulation of immune responses by TGF-beta. Annu. Rev. Immunol. 16:137-161.
53. Seddon, B., and Mason, D. 1999. Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD45RC-cells and CD4(+)CD8(-) thymocytes. J. Exp. Med. 189:279-288.
54. Weller, M., Constam, D.B., Malipiero, U., and Fontana, A. 1994. Transforming growth factor-beta 2 induces apoptosis of murine T cell clones without down-regulating bcl-2 mRNA expression. Eur. J. Immunol. 24:1293-1300.
55. Thorbecke, G.J., Schwarcz, R., Leu, J., Huang, C., and Simmons, W.J. 1999. Modulation by cytokines of induction of oral tolerance to type II collagen. Arthritis Rheum. 42:110-118.
56. Chelen, C.J., et al. 1995. Human alveolar macrophages present antigen ineffectively due to defective expression of B7 costimulatory cell surface molecules. J Clin. Invest. 95:1415-1421.
57. Tillie-Leblond, I., et al. 1999. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am. J. Respir. Crit. Care Med. 159:487-494.